News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
761,133 Results
Type
Article (56573)
Company Profile (291)
Press Release (704268)
Multimedia
Podcasts (92)
Webinars (15)
Section
Business (215925)
Career Advice (2948)
Deals (37178)
Drug Delivery (117)
Drug Development (86029)
Employer Resources (184)
FDA (17331)
Job Trends (15933)
News (366764)
Policy (35482)
Tag
Academia (2906)
Accelerated approval (11)
Adcomms (32)
Allergies (104)
Alliances (53582)
ALS (119)
Alzheimer's disease (1538)
Antibody-drug conjugate (ADC) (180)
Approvals (17291)
Artificial intelligence (367)
Autoimmune disease (35)
Automation (18)
Bankruptcy (389)
Best Places to Work (12199)
BIOSECURE Act (21)
Biosimilars (130)
Biotechnology (200)
Bladder cancer (100)
Brain cancer (38)
Breast cancer (388)
Cancer (3041)
Cardiovascular disease (244)
Career advice (2476)
Career pathing (34)
CAR-T (206)
CDC (39)
Cell therapy (550)
Cervical cancer (23)
Clinical research (70493)
Collaboration (1092)
Company closure (3)
Compensation (711)
Complete response letters (30)
COVID-19 (2867)
CRISPR (65)
C-suite (347)
Cystic fibrosis (119)
Data (3063)
Decentralized trials (2)
Denatured (21)
Depression (75)
Diabetes (374)
Diagnostics (6779)
Digital health (24)
Diversity (9)
Diversity, equity & inclusion (47)
Drug discovery (161)
Drug pricing (147)
Drug shortages (33)
Duchenne muscular dystrophy (130)
Earnings (90227)
Editorial (47)
Employer branding (22)
Employer resources (159)
Events (120075)
Executive appointments (902)
FDA (19052)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (992)
Gene editing (143)
Generative AI (31)
Gene therapy (422)
GLP-1 (905)
Government (4976)
Grass and pollen (6)
Guidances (181)
Healthcare (20181)
HIV (45)
Huntington's disease (32)
IgA nephropathy (43)
Immunology and inflammation (176)
Immuno-oncology (8)
Indications (40)
Infectious disease (3064)
Inflammatory bowel disease (160)
Inflation Reduction Act (11)
Influenza (69)
Intellectual property (123)
Interviews (552)
IPO (17109)
IRA (49)
Job creations (4148)
Job search strategy (2052)
Kidney cancer (14)
Labor market (53)
Layoffs (563)
Leadership (26)
Legal (8720)
Liver cancer (85)
Longevity (12)
Lung cancer (428)
Lymphoma (213)
Machine learning (11)
Management (62)
Manufacturing (425)
MASH (98)
Medical device (14269)
Medtech (14274)
Mergers & acquisitions (20801)
Metabolic disorders (937)
Multiple sclerosis (104)
NASH (23)
Neurodegenerative disease (138)
Neuropsychiatric disorders (41)
Neuroscience (2286)
NextGen: Class of 2025 (7150)
Non-profit (4919)
Now hiring (47)
Obesity (479)
Opinion (288)
Ovarian cancer (104)
Pain (120)
Pancreatic cancer (125)
Parkinson's disease (198)
Partnered (22)
Patents (316)
Patient recruitment (170)
Peanut (55)
People (61065)
Pharmaceutical (72)
Pharmacy benefit managers (24)
Phase I (21900)
Phase II (30867)
Phase III (23208)
Pipeline (1679)
Policy (228)
Postmarket research (2873)
Preclinical (9476)
Press Release (72)
Prostate cancer (148)
Psychedelics (42)
Radiopharmaceuticals (271)
Rare diseases (515)
Real estate (6545)
Recruiting (71)
Regulatory (24478)
Reports (52)
Research institute (2587)
Resumes & cover letters (472)
Rett syndrome (10)
RNA editing (9)
RSV (58)
Schizophrenia (98)
Series A (166)
Series B (116)
Service/supplier (14)
Sickle cell disease (67)
Special edition (20)
Spinal muscular atrophy (163)
Sponsored (37)
Startups (3915)
State (2)
Stomach cancer (17)
Supply chain (82)
Tariffs (63)
The Weekly (69)
Vaccines (899)
Venture capital (57)
Weight loss (312)
Women's health (47)
Worklife (20)
Date
Today (73)
Last 7 days (399)
Last 30 days (2017)
Last 365 days (33122)
2025 (17911)
2024 (36937)
2023 (41638)
2022 (52950)
2021 (57651)
2020 (56507)
2019 (49721)
2018 (37696)
2017 (34584)
2016 (34432)
2015 (40408)
2014 (34126)
2013 (31891)
2012 (31507)
2011 (32134)
2010 (30396)
Location
Africa (949)
Alabama (64)
Alaska (7)
Arizona (261)
Arkansas (14)
Asia (43411)
Australia (7338)
California (7645)
Canada (2394)
China (714)
Colorado (330)
Connecticut (342)
Delaware (197)
Europe (95665)
Florida (1152)
Georgia (253)
Hawaii (1)
Idaho (65)
Illinois (676)
India (28)
Indiana (373)
Iowa (17)
Japan (235)
Kansas (112)
Kentucky (32)
Louisiana (15)
Maine (65)
Maryland (1071)
Massachusetts (5753)
Michigan (252)
Minnesota (466)
Mississippi (3)
Missouri (93)
Montana (31)
Nebraska (25)
Nevada (81)
New Hampshire (71)
New Jersey (2137)
New Mexico (31)
New York (2153)
North Carolina (1179)
North Dakota (10)
Northern California (3342)
Ohio (243)
Oklahoma (17)
Oregon (37)
Pennsylvania (1639)
Puerto Rico (17)
Rhode Island (36)
South America (1345)
South Carolina (36)
South Dakota (1)
Southern California (2858)
Tennessee (129)
Texas (1151)
United States (28562)
Utah (226)
Virginia (194)
Washington D.C. (77)
Washington State (647)
West Virginia (4)
Wisconsin (80)
761,133 Results for "si bone inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
SI-BONE To Report Second Quarter 2025 Financial Results on August 4, 2025
July 15, 2025
·
1 min read
Press Releases
SI-BONE to Truist Securities MedTech Conference on June 17, 2025
June 5, 2025
·
1 min read
Press Releases
SI-BONE, Inc. Reports Financial Results for the First Quarter 2025 and Updates 2025 Guidance
May 6, 2025
·
9 min read
Press Releases
SI-BONE to Present at Truist Securities MedTech Conference on June 17, 2025
June 5, 2025
·
1 min read
Press Releases
SI-BONE to Present at Goldman Sachs 46th Global Healthcare Conference on June 10, 2025
May 29, 2025
·
1 min read
Press Releases
SI-BONE To Present at BofA Securities 2025 Healthcare Conference on May 13, 2025
May 7, 2025
·
1 min read
Press Releases
SI-BONE To Report First Quarter 2025 Financial Results on May 5, 2025
April 15, 2025
·
1 min read
Press Releases
SI-BONE, Inc. Reports Record Financial Results for the Fourth Quarter 2024 and Issues 2025 Guidance
February 25, 2025
·
10 min read
Business
SI-BONE, Inc. Reports Financial Results for the First Quarter 2024
SI-BONE, Inc., a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, reported financial results for the quarter ended March 31, 2024.
May 6, 2024
·
8 min read
Biotech Bay
SI-BONE To Present at Truist Securities 2024 MedTech Conference on June 18, 2024
SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced that the company will be participating in the upcoming 2024 Truist Securities MedTech Conference in Boston.
June 5, 2024
·
1 min read
1 of 76,114
Next
